本文選題：脾動脈栓塞 + 射頻消融術　； 參考：《山東醫(yī)藥》2017年34期

【摘要】：目的觀察部分脾動脈栓塞(PSE)聯(lián)合腹腔鏡下射頻消融術(RFA)治療脾功能亢進癥的臨床效果。方法將42例慢性乙型肝炎引起的肝硬化性門靜脈高壓所致脾功能亢進癥患者隨機分為觀察組23例和對照組19例,對照組僅實施PSE治療,觀察組給予PSE聯(lián)合腹腔鏡下RFA治療。觀察并記錄術后并發(fā)癥發(fā)生情況;術后隨訪6個月以上,定期復查血常規(guī)。結果兩組術后第3、14天及第6個月外周血WBC、PLT均較術前明顯升高(P均0.05),術后各時點RBC較術前升高不明顯(P均0.05)。觀察組術后各時點外周血WBC、PLT、RBC與對照組比較,差異均無統(tǒng)計學意義(P均0.05)。觀察組術后并發(fā)癥發(fā)生率均低于對照組(P0.05)。結論 PSE聯(lián)合腹腔鏡下RFA治療門靜脈高壓性脾功能亢進癥安全有效。
[Abstract]:Objective To observe the clinical effect of partial splenic artery embolization (PSE) combined with laparoscopic radiofrequency ablation (RFA) in the treatment of hypersplenism. Methods 42 patients with Hypersplenism Caused by cirrhosis caused by portal hypertension were randomly divided into 23 cases and 19 cases in the control group, and the control group was only treated with PSE, the observation group was given. PSE combined with laparoscopic RFA treatment. Observe and record the incidence of postoperative complications; follow up for more than 6 months after the operation, and check the blood routine regularly. Results the two groups after 3,14 day and 6 months of peripheral blood WBC, PLT were significantly higher than before operation (P 0.05), RBC after the operation was not significantly higher than before the operation (P 0.05). There was no significant difference in WBC, PLT, RBC between the peripheral blood and the control group (P 0.05). The incidence of postoperative complications in the observation group was lower than that of the control group (P0.05). Conclusion PSE combined with laparoscopic RFA in the treatment of hyperbaric hypersplenism with portal hypertension is safe and effective.

【作者單位】： 濰坊市人民醫(yī)院;濰坊醫(yī)學院臨床醫(yī)學院;
【基金】：山東省濰坊市科技計劃項目(2014WS015)
【分類號】：R575.2

【相似文獻】

相關期刊論文 前10條

1 馬寬生,吳喬,劉全達,別平,董家鴻;射頻消融治療脾功能亢進癥的臨床研究[J];中華外科雜志;2004年15期

2 錢小星;楊春建;劉咸羅;吳茂松;陳克輝;胡鋼;;部分脾動脈栓塞術治療脾功能亢進癥臨床觀察[J];實用肝臟病雜志;2012年05期

3 劉雪蓮;楊見權;;脾功能亢進癥治療進展[J];實用肝臟病雜志;2013年04期

4 吳宇旋;張彥舫;鄭雪芬;張媛華;孔健;沈新穎;竇永充;;經皮射頻消融治療脾功能亢進癥[J];介入放射學雜志;2009年05期

5 何津祥;靳p，

本文編號：1810087